Cancer Targeted Therapy Market Research: Global Status & Forecast by Geography, Type & Application (2017-2027)

Region:Global

Author(s):

Product Code:99SGL228Lif202107000028775

Download Sample Report download
Buy the Full ReportStarting from $2280
Published on

October 2021

Total pages

84

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $2280

About the Report

About the Report

According to 99Strategy, the Global Cancer Targeted Therapy Market is estimated to reach xxx million USD in 2021 and projected to grow at the CAGR of xx% during the 2022-2027. The report analyses the global Cancer Targeted Therapy market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific

North America

Europe

South America

Middle East & Africa

Key Companies

Advaxis

Bind Therapeutics

Boehringer Ingelheim

Bristol Mayer Squibb

Celldex Therapeutics

Dendreon Corporation

Eli Lily

GalaxoSmithKline

Galena Biopharma

Genetech

ImmunoCellular Therapeutics

ImmunoGen

Inovio Pharmaceuticals

Johnson & Johnson

NeoStem Oncology

NewLink Genetics

Northwest Biotherapeutics

Merck

Novartis

Peregrine Pharmaceuticals

Pfizer

Roche

Sanofi

Seattle Genetics

Teva

Key Product Type

Tumor Antigens As Targets of Antibodies

Development of Antibodies for Clinical Purposes

Complement Dependent Cytotoxicity (CDC)

Signal Transduction Changes

Market by Application

Hospital

Clinic

Others

Main Aspects covered in the Report

Overview of the Cancer Targeted Therapy market including production, consumption, status & forecast and market growth

2017-2021 historical data and 2022-2027 market forecast

Geographical analysis including major countries

Overview the product type market including development

Overview the end-user market including development

Products

Table of Contents

Table of Contents

Table of Content

1 Industrial Chain Overview

1.1 Cancer Targeted Therapy Industry

1.1.1 Overview

Figure Cancer Targeted Therapy Picture List

1.1.2 Characteristics of Cancer Targeted Therapy

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 Tumor Antigens As Targets of Antibodies

1.3.2 Development of Antibodies for Clinical Purposes

1.3.3 Complement Dependent Cytotoxicity (CDC)

1.3.4 Signal Transduction Changes

1.4 End-Use List

1.4.1 Demand in Hospital

1.4.2 Demand in Clinic

1.4.3 Demand in Others

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2017-2027

Figure Global Market Size and Forecast with Growth Rate, 2017-2027

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2017-2027

Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2017-2027

Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2017-2027

Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume

Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume

Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD

2.1.2 Global Consumption

Figure Global Market Volume and Growth Rate, 2017-2021, in Volume

Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume

Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD

Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.1.2 North America

Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume

Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.1.3 South America

Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume

Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.1.4 Europe

Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume

Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.1.5 Middle East & Africa

Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

2.2.2 Consumption

2.2.2.1 Asia-Pacific

Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume

Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD

Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.2 North America

Figure North America Market Volume and Growth Rate, 2017-2021, in Volume

Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD

Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.3 South America

Figure South America Market Volume and Growth Rate, 2017-2021, in Volume

Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD

Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.4 Europe

Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume

Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD

Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD

2.2.2.5 Middle East & Africa

Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume

Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD

Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2021

3.2 Manufacturers List

3.2.1 Advaxis Overview

Table Advaxis Overview List

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Advaxis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 Bind Therapeutics Overview

Table Bind Therapeutics Overview List

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Bind Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 Boehringer Ingelheim Overview

Table Boehringer Ingelheim Overview List

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Boehringer Ingelheim (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 Bristol Mayer Squibb Overview

Table Bristol Mayer Squibb Overview List

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Bristol Mayer Squibb (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 Celldex Therapeutics Overview

Table Celldex Therapeutics Overview List

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Celldex Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 Dendreon Corporation Overview

Table Dendreon Corporation Overview List

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Dendreon Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Eli Lily Overview

Table Eli Lily Overview List

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Eli Lily (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 GalaxoSmithKline Overview

Table GalaxoSmithKline Overview List

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of GalaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 Galena Biopharma Overview

Table Galena Biopharma Overview List

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Galena Biopharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 Genetech Overview

Table Genetech Overview List

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Genetech (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 ImmunoCellular Therapeutics Overview

Table ImmunoCellular Therapeutics Overview List

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of ImmunoCellular Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 ImmunoGen Overview

Table ImmunoGen Overview List

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of ImmunoGen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 Inovio Pharmaceuticals Overview

Table Inovio Pharmaceuticals Overview List

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Inovio Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 Johnson & Johnson Overview

Table Johnson & Johnson Overview List

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 NeoStem Oncology Overview

Table NeoStem Oncology Overview List

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of NeoStem Oncology (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 NewLink Genetics Overview

Table NewLink Genetics Overview List

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of NewLink Genetics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

3.2.17 Northwest Biotherapeutics Overview

Table Northwest Biotherapeutics Overview List

3.2.17.1 Product Specifications

3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Northwest Biotherapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.17.3 Recent Developments

3.2.17.4 Future Strategic Planning

3.2.18 Merck Overview

Table Merck Overview List

3.2.18.1 Product Specifications

3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Merck (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.18.3 Recent Developments

3.2.18.4 Future Strategic Planning

3.2.19 Novartis Overview

Table Novartis Overview List

3.2.19.1 Product Specifications

3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Novartis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.19.3 Recent Developments

3.2.19.4 Future Strategic Planning

3.2.20 Peregrine Pharmaceuticals Overview

Table Peregrine Pharmaceuticals Overview List

3.2.20.1 Product Specifications

3.2.20.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Peregrine Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.20.3 Recent Developments

3.2.20.4 Future Strategic Planning

3.2.21 Pfizer Overview

Table Pfizer Overview List

3.2.21.1 Product Specifications

3.2.21.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.21.3 Recent Developments

3.2.21.4 Future Strategic Planning

3.2.22 Roche Overview

Table Roche Overview List

3.2.22.1 Product Specifications

3.2.22.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Roche (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.22.3 Recent Developments

3.2.22.4 Future Strategic Planning

3.2.23 Sanofi Overview

Table Sanofi Overview List

3.2.23.1 Product Specifications

3.2.23.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Sanofi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.23.3 Recent Developments

3.2.23.4 Future Strategic Planning

3.2.24 Seattle Genetics Overview

Table Seattle Genetics Overview List

3.2.24.1 Product Specifications

3.2.24.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Seattle Genetics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.24.3 Recent Developments

3.2.24.4 Future Strategic Planning

3.2.25 Teva Overview

Table Teva Overview List

3.2.25.1 Product Specifications

3.2.25.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Cancer Targeted Therapy Business Operation of Teva (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.25.3 Recent Developments

3.2.25.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

Figure Global Market Size and Growth Rate, 2017-2021, in Volume

Figure Global Market Size and Growth Rate, 2017-2021, in Million USD

Figure Global Competition Sketch Overview

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

Table Global Production Volume List by Manufacturers, 2017-2021, in Volume

Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume

Figure Global Production Volume Share by Manufacturers in 2021, in Volume

Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD

Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD

Figure Global Production Amount Share by Manufacturers in 2021, in Million USD

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume

5.2 Segment Subdivision by Product Type

5.2.1 Market in Tumor Antigens As Targets of Antibodies

5.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Tumor Antigens As Targets of Antibodies , 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Tumor Antigens As Targets of Antibodies , 2017-2021, in Volume

5.2.1.2 Situation & Development

5.2.2 Market in Development of Antibodies for Clinical Purposes

5.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Development of Antibodies for Clinical Purposes , 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Development of Antibodies for Clinical Purposes , 2017-2021, in Volume

5.2.2.2 Situation & Development

5.2.3 Market in Complement Dependent Cytotoxicity (CDC)

5.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in Complement Dependent Cytotoxicity (CDC) , 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Complement Dependent Cytotoxicity (CDC) , 2017-2021, in Volume

5.2.3.2 Situation & Development

5.2.4 Market in Signal Transduction Changes

5.2.4.1 Market Size

Figure Global Market Amount and Growth Rate in Signal Transduction Changes, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Signal Transduction Changes, 2017-2021, in Volume

5.2.4.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume

6.2 Segment Subdivision

6.2.1 Market in Hospital

6.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Hospital , 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Hospital , 2017-2021, in Volume

6.2.1.2 Situation & Development

6.2.2 Market in Clinic

6.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Clinic , 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Clinic , 2017-2021, in Volume

6.2.2.2 Situation & Development

6.2.3 Market in Others

6.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2017-2021, in Volume

6.2.3.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

Table Global Market Forecast by Region Segment 2022-2027, in Million USD

Table Global Market Forecast by Region Segment 2022-2027, in Volume

7.2 Consumption Forecast

7.2.1 Product Type Forecast

Table Global Market Amount by Product Type Segment 2022-2027, in Million USD

Table Global Market Volume by Product Type Segment 2022-2027, in Volume

7.2.2 End-Use Forecast

Table Global Market Amount by End-Use Segment 2022-2027, in Million USD

Table Global Market Volume by End-Use Segment 2022-2027, in Volume

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

Figure Cost Component Ratio

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

9.3 Impact of Coronavirus on the Cancer Targeted Therapy Industry

9.3.1 Impact on Industry Upstream

9.3.2 Impact on Industry Downstream

9.3.3 Impact on Industry Channels

9.3.4 Impact on Industry Competition

9.3.5 Impact on Industry Employment

10 Research Conclusion


List of Figure

List of Figure

Figure Cancer Targeted Therapy Picture List

Figure Global Market Size and Forecast with Growth Rate, 2017-2027

Figure Global Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure Global Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure Global Market Volume and Growth Rate, 2017-2021, in Volume

Figure Global Market Amount and Growth Rate, 2017-2021, in Million USD

Figure Asia-Pacific Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure North America Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure North America Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure South America Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure South America Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure Europe Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure Europe Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure Middle East & Africa Production Volume Status and Growth Rate, 2017-2021, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2017-2021, in Million USD

Figure Asia-Pacific Market Volume and Growth Rate, 2017-2021, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2017-2021, in Million USD

Figure North America Market Volume and Growth Rate, 2017-2021, in Volume

Figure North America Market Amount and Growth Rate, 2017-2021, in Million USD

Figure South America Market Volume and Growth Rate, 2017-2021, in Volume

Figure South America Market Amount and Growth Rate, 2017-2021, in Million USD

Figure Europe Market Volume and Growth Rate, 2017-2021, in Volume

Figure Europe Market Amount and Growth Rate, 2017-2021, in Million USD

Figure Middle East & Africa Market Volume and Growth Rate, 2017-2021, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2017-2021, in Million USD

Figure Global Market Size and Growth Rate, 2017-2021, in Volume

Figure Global Market Size and Growth Rate, 2017-2021, in Million USD

Figure Global Competition Sketch Overview

Figure Global Production Volume Share by Manufacturers in 2021, in Volume

Figure Global Production Amount Share by Manufacturers in 2021, in Million USD

Figure Global Market Amount and Growth Rate in Tumor Antigens As Targets of Antibodies , 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Tumor Antigens As Targets of Antibodies , 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Development of Antibodies for Clinical Purposes , 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Development of Antibodies for Clinical Purposes , 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Complement Dependent Cytotoxicity (CDC) , 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Complement Dependent Cytotoxicity (CDC) , 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Signal Transduction Changes, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Signal Transduction Changes, 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Hospital , 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Hospital , 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Clinic , 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Clinic , 2017-2021, in Volume

Figure Global Market Amount and Growth Rate in Others, 2017-2021, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2017-2021, in Volume

Figure Cost Component Ratio


List of Table

List of Table

Table Global Market Size and Forecast by Geography with Growth Rate, 2017-2027

Table Global Market Size and Forecast by Type with Growth Rate, 2017-2027

Table Global Market Size and Forecast by End-Use with Growth Rate, 2017-2027

Table Global Production Volume Status and Growth Rate by Geography, 2017-2021, in Volume

Table Global Production Amount Status and Growth Rate by Geography, 2017-2021, in Million USD

Table Global Market Volume and Growth Rate by Geography, 2017-2021, in Volume

Table Global Market Amount and Growth Rate by Geography, 2017-2021, in Million USD

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

Table North America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Table North America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

Table South America Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Table South America Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

Table Europe Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Table Europe Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2017-2021, in Volume

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2017-2021, in Million USD

Table Asia-Pacific Market Volume and Growth Rate by Region, 2017-2021, in Volume

Table Asia-Pacific Market Amount and Growth Rate by Region, 2017-2021, in Million USD

Table North America Market Volume and Growth Rate by Region, 2017-2021, in Volume

Table North America Market Amount and Growth Rate by Region, 2017-2021, in Million USD

Table South America Market Volume and Growth Rate by Region, 2017-2021, in Volume

Table South America Market Amount and Growth Rate by Region, 2017-2021, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2017-2021, in Volume

Table Europe Market Amount and Growth Rate by Region, 2017-2021, in Million USD

Table Middle East & Africa Market Volume and Growth Rate by Region, 2017-2021, in Volume

Table Middle East & Africa Market Amount and Growth Rate by Region, 2017-2021, in Million USD

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2021

Table Advaxis Overview List

Table Cancer Targeted Therapy Business Operation of Advaxis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Bind Therapeutics Overview List

Table Cancer Targeted Therapy Business Operation of Bind Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Boehringer Ingelheim Overview List

Table Cancer Targeted Therapy Business Operation of Boehringer Ingelheim (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Bristol Mayer Squibb Overview List

Table Cancer Targeted Therapy Business Operation of Bristol Mayer Squibb (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Celldex Therapeutics Overview List

Table Cancer Targeted Therapy Business Operation of Celldex Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Dendreon Corporation Overview List

Table Cancer Targeted Therapy Business Operation of Dendreon Corporation (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Eli Lily Overview List

Table Cancer Targeted Therapy Business Operation of Eli Lily (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table GalaxoSmithKline Overview List

Table Cancer Targeted Therapy Business Operation of GalaxoSmithKline (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Galena Biopharma Overview List

Table Cancer Targeted Therapy Business Operation of Galena Biopharma (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Genetech Overview List

Table Cancer Targeted Therapy Business Operation of Genetech (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table ImmunoCellular Therapeutics Overview List

Table Cancer Targeted Therapy Business Operation of ImmunoCellular Therapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table ImmunoGen Overview List

Table Cancer Targeted Therapy Business Operation of ImmunoGen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Inovio Pharmaceuticals Overview List

Table Cancer Targeted Therapy Business Operation of Inovio Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Cancer Targeted Therapy Business Operation of Johnson & Johnson (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table NeoStem Oncology Overview List

Table Cancer Targeted Therapy Business Operation of NeoStem Oncology (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table NewLink Genetics Overview List

Table Cancer Targeted Therapy Business Operation of NewLink Genetics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Northwest Biotherapeutics Overview List

Table Cancer Targeted Therapy Business Operation of Northwest Biotherapeutics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Merck Overview List

Table Cancer Targeted Therapy Business Operation of Merck (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Novartis Overview List

Table Cancer Targeted Therapy Business Operation of Novartis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Peregrine Pharmaceuticals Overview List

Table Cancer Targeted Therapy Business Operation of Peregrine Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Cancer Targeted Therapy Business Operation of Pfizer (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Roche Overview List

Table Cancer Targeted Therapy Business Operation of Roche (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Sanofi Overview List

Table Cancer Targeted Therapy Business Operation of Sanofi (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Seattle Genetics Overview List

Table Cancer Targeted Therapy Business Operation of Seattle Genetics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Teva Overview List

Table Cancer Targeted Therapy Business Operation of Teva (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Global Production Volume List by Manufacturers, 2017-2021, in Volume

Table Global Production Volume Share List by Manufacturers, 2017-2021, in Volume

Table Global Production Amount List by Manufacturers, 2017-2021, in Million USD

Table Global Production Amount Share List by Manufacturers, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2017-2021, in Volume

Table Global Market Status and Growth Rate by End-Use Segment, 2017-2021, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2017-2021, in Volume

Table Global Market Forecast by Region Segment 2022-2027, in Million USD

Table Global Market Forecast by Region Segment 2022-2027, in Volume

Table Global Market Amount by Product Type Segment 2022-2027, in Million USD

Table Global Market Volume by Product Type Segment 2022-2027, in Volume

Table Global Market Amount by End-Use Segment 2022-2027, in Million USD

Table Global Market Volume by End-Use Segment 2022-2027, in Volume

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022